## Abstract The following are policies, guidelines, and recommendations from the Safety Committee of the Society for Magnetic Resonance Imaging (SMRI) concerning various issues related to magnetic resonance (MR) imaging safety and patient management. These policies, guidelines, and recommendations
Policies, guidelines, and recommendations for MR imaging safety and patient management
โ Scribed by Frank G. Shellock
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 585 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.
โฆ Synopsis
The following are policies, guidelines, and recommendations from the Safety Committee of the Society for Magnetic Resonance Imaging (SMRI) concerning various issues related to magnetic resonance (MR) imaging safety and patient management. These policies, guidelines, and recommendations were developed to provide standardized and consistent information for use by health practitioners involved in clinical MR imaging.
๐ SIMILAR VOLUMES
## Abstract The authors present the third installment of the guidelines and recommendations from the Safety Committee of the Society for Magnetic Resonance Imaging (now the Society of Magnetic Resonance) concerning various issues related to the safety and management of patients undergoing magnetic
## Abstract ## BACKGROUND: Hospitalists are poised to have a tremendous impact on improving the quality of care for hospitalized patients. However, many hospitalists are inadequately prepared to engage in efforts to improve quality, because medical schools and residency programs have not tradition
This paper reviews some of the literature and guidance provided for businesses considering responses to the environmental aspects and impacts of their tourist activities. It concentrates on the role of individual business organizations within the tourism industry and examines both supply-side (produ
## Abstract Twenty patients with malignant liver lesions underwent magnetic resonance (MR) imaging with manganese (II) DPDP [__N__,__N__โฒโdipyridoxylethylenediamineโ__N__,__N__โฒโdiacetate 5,5โฒโbis(phosphate)] to evaluate the safety and efficacy of the contrast agent. In two groups of 10 patients ea